NCT00882037 is a clinical trial in Methamphetamine Dependence, sponsored by University of Nebraska.

Who is sponsoring NCT00882037?

NCT00882037 is sponsored by University of Nebraska.

What condition does NCT00882037 study?

NCT00882037 studies Methamphetamine Dependence.

Is NCT00882037 still recruiting?

NCT00882037 is currently completed. Last updated 29 September 2023.

Last reviewed 2023-09-29 · How we verify

NCT00882037

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Risk and Protective Factors for Rural Methamphetamine Dependence

Completed Last updated 29 September 2023

What this trial tests

trial in Methamphetamine Dependence in 133 participants. Completed in 15 December 2010.

Timeline

12 December 2008

Primary endpoint
15 December 2010

15 December 2010

Quick facts

Lead sponsor	University of Nebraska
Status	Completed
Study type	OBSERVATIONAL
Enrollment	133
Start date	12 December 2008
Primary completion	15 December 2010
Estimated completion	15 December 2010
Sites	2 locations across United States

Conditions studied

Methamphetamine Dependence — all drugs for Methamphetamine Dependence →

Sponsor

University of Nebraska

Who can join

18 and older, any sex, with Methamphetamine Dependence. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The primary goal of this study is to identify factors which may put a person that has used methamphetamine at greater risk for mental and physical health problems and social problems and factors that may lessen the risk for these problems. This study will also compare methamphetamine use between Latino and non-Latino persons and those that live in a rural area or urban area. The investigators hypothesis is that rural persons with methamphetamine dependence will have greater socio-demographic, bio-psychosocial and behavioral risk factors than their urban counterparts.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other University of Nebraska trials

Trials by the same sponsor.

NCT07507006 — Feasibility Study of the Flash-Sole: A Wearable Midsole With Soft Actuators for Walking Assistance · NA · not yet recruiting
NCT07517705 — MRD-Adapted Low-Dose Radiation Therapy During Frontline Chemoimmunotherapy for Diffuse Large B-Cell Lymphoma · NA · not yet recruiting
NCT07506993 — Inflammation in Clear Aligners With and Without Attachments · not yet recruiting
NCT07207850 — Parents Helping Parents for Youth Vaping Cessation · NA · not yet recruiting
NCT07237269 — Abi/Pred + ADT vs ADT in PSMA-Positive, Conventionally Node-Negative Prostate Cancer · Phase 2 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT00882037 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Nebraska
Last refreshed: 29 September 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT00882037.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing